comparemela.com

Latest Breaking News On - Ronen tsimerman - Page 7 : comparemela.com

IceCure Medical to Report Q1 2022 Results and Conduct Conference Call May 18, 2022

/PRNewswire/ IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.

United statesRonen tsimermanCompany annual report on formIsrael internationalPrnewswire icecure medical ltdBreast centerDrug administrationAmerican society of breast surgeonsCure medicalRichard fineAmerican societyBreast surgeonsProgram directorBreast surgical oncology fellowshipWest comprehensive breast centerIsrael based icecure medical

IceCure Medical Presents ICE3 Breast Cancer Trial Interim Data, Hosts Cryoablation Symposium & Conducts Hands-On ProSense® Training Sessions at the European Conference on Interventional Oncology

/PRNewswire/ IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.

Franco orsiGhizlane touimi benjellounIcecure prosenseKennethr tomkovichRonen tsimermanEyal shamirYair halpernCompany annual report on formPrnewswire icecure medical ltdDrug administrationEuropean institute of oncologyBnei zion medical centerCure medicalEuropean conferenceInterventional oncologyLiquid nitrogen

vimarsana © 2020. All Rights Reserved.